BRPI0615958B8 - composição para aumentar a permeabilidade de paredes celulares e membranas celulares de mycobacterium sp. e método para detectar um alvo em uma célula - Google Patents

composição para aumentar a permeabilidade de paredes celulares e membranas celulares de mycobacterium sp. e método para detectar um alvo em uma célula

Info

Publication number
BRPI0615958B8
BRPI0615958B8 BRPI0615958A BRPI0615958A BRPI0615958B8 BR PI0615958 B8 BRPI0615958 B8 BR PI0615958B8 BR PI0615958 A BRPI0615958 A BR PI0615958A BR PI0615958 A BRPI0615958 A BR PI0615958A BR PI0615958 B8 BRPI0615958 B8 BR PI0615958B8
Authority
BR
Brazil
Prior art keywords
cell
target
pathogen
mycobacterium
permeability
Prior art date
Application number
BRPI0615958A
Other languages
English (en)
Inventor
S Shah Jyotsama
Original Assignee
Id Fish Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Fish Tech Inc filed Critical Id Fish Tech Inc
Publication of BRPI0615958A2 publication Critical patent/BRPI0615958A2/pt
Publication of BRPI0615958B1 publication Critical patent/BRPI0615958B1/pt
Publication of BRPI0615958B8 publication Critical patent/BRPI0615958B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

composição para aumentar a permeabilidade de paredes celulares, membranas celulares e membranas nucleares e método para detectar um alvo em uma célula. a presente invenção provê um método para permitir que partículas externas penetrem, mais eficientemente, à parede celular, membrana celular, membrana de organelas e/ou membrana nuclear de uma célula e que hibridize ou se ligue a um alvo complementar na célula. as células podem ser de uma cultura ou a partir de uma espécie obtida a partir de um paciente. a partícula externa pode ser uma sonda consistindo de, por exemplo, tanto individualmente quanto em qualquer combinação de dois ou mais de: dna, rna, ácidos nucléicos de peptídeos (pna), glicopeptídeos, lipopeptídeos, glicolipidios e prions. o alvo é uma célula, um componente celular ou, preferivelmente, um patógeno ou componente de patógeno. o patógeno pode ser, por exemplo, bactéria, fungo, levedura ou vírus.
BRPI0615958A 2005-07-28 2006-07-27 composição para aumentar a permeabilidade de paredes celulares e membranas celulares de mycobacterium sp. e método para detectar um alvo em uma célula BRPI0615958B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70332905P 2005-07-28 2005-07-28
US60/703,329 2005-07-28
PCT/US2006/029501 WO2007016379A2 (en) 2005-07-28 2006-07-27 Method for improving cell permeability to foreign particles

Publications (3)

Publication Number Publication Date
BRPI0615958A2 BRPI0615958A2 (pt) 2011-05-31
BRPI0615958B1 BRPI0615958B1 (pt) 2020-11-10
BRPI0615958B8 true BRPI0615958B8 (pt) 2021-05-25

Family

ID=37709226

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0615958A BRPI0615958B8 (pt) 2005-07-28 2006-07-27 composição para aumentar a permeabilidade de paredes celulares e membranas celulares de mycobacterium sp. e método para detectar um alvo em uma célula

Country Status (16)

Country Link
US (1) US8632963B2 (pt)
EP (1) EP1924252B1 (pt)
JP (1) JP5132557B2 (pt)
CN (1) CN101272773A (pt)
AT (1) ATE523193T1 (pt)
AU (1) AU2006275632B2 (pt)
BR (1) BRPI0615958B8 (pt)
CA (1) CA2641599C (pt)
CY (1) CY1111959T1 (pt)
DK (1) DK1924252T3 (pt)
ES (1) ES2372538T3 (pt)
PL (1) PL1924252T3 (pt)
PT (1) PT1924252E (pt)
SI (1) SI1924252T1 (pt)
WO (1) WO2007016379A2 (pt)
ZA (1) ZA200801859B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758990B2 (en) * 2005-07-28 2014-06-24 Id-Fish Technology, Inc. Methods for detecting and differentiating Mycobacterium genus and Mycobacterium avium complex in a sample or culture
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8323901B2 (en) * 2006-11-30 2012-12-04 Id-Fish Technology, Inc. Nucleic acid probes and methods for detecting plasmodium parasites
ES2471092T3 (es) * 2006-11-30 2014-06-25 Id-Fish Technology, Inc. Sondas de ácido nucleico y métodos para detectar parásitos de Plasmodium
JP5241100B2 (ja) * 2006-12-28 2013-07-17 シスメックス株式会社 抗原賦活化液、抗原賦活化方法及び細胞の検出方法
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
DK2195466T3 (da) * 2007-10-01 2013-01-14 Longhorn Vaccines & Diagnostics Llc Fremgangsmåde til opbevaring af biologiske prøver
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
SG171914A1 (en) 2008-12-02 2011-07-28 Chiralgen Ltd Method for the synthesis of phosphorus atom modified nucleic acids
EP2451461A4 (en) 2009-07-06 2013-05-29 Ontorii Inc NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
DK2620428T3 (da) 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
US9605019B2 (en) 2011-07-19 2017-03-28 Wave Life Sciences Ltd. Methods for the synthesis of functionalized nucleic acids
CN112007045B (zh) 2012-07-13 2026-01-06 波涛生命科学有限公司 手性控制
DK2872485T3 (da) 2012-07-13 2021-03-08 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
JP6246121B2 (ja) 2012-07-13 2017-12-13 株式会社新日本科学 キラル核酸アジュバント
WO2015108048A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
EP3095461A4 (en) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
KR102423317B1 (ko) 2014-01-16 2022-07-22 웨이브 라이프 사이언시스 리미티드 키랄 디자인
CN107367417B (zh) * 2017-07-14 2021-06-22 上海市松江区中心医院 一种超声引导下穿刺细胞快速固定剂组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521300A (en) 1991-08-13 1996-05-28 Norval B. Galloway Oligonucleotides complementary to mycobacterial nucleic acids
US5422277A (en) 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
DE69327454T2 (de) 1992-10-09 2000-05-11 Vysis, Inc. Analytisches verfahren
US6538107B1 (en) * 1994-09-30 2003-03-25 Takeda Chemical Industries, Ltd. G protein coupled receptor protein production, and use thereof
US6720355B2 (en) * 1997-02-21 2004-04-13 The Regents Of The University Of California Sodium dodecyl sulfate compositions for inactivating prions
EP2138191A1 (en) * 1998-01-05 2009-12-30 University Of Washington Enhanced transport using membrane disruptive agents
US5985571A (en) * 1998-02-04 1999-11-16 Ludwig Institute For Cancer Research Method for determining multiple myeloma by assaying for expression of mage genes
DE69942309D1 (de) * 1998-05-18 2010-06-10 Igenex Inc In situ hybridisierungsverfahren zur entdeckung von zielnukleinsäuren
EP1654361B2 (en) * 2003-07-25 2023-01-18 Life Technologies Corporation Methods and compositions for preparing rna from a fixed sample
US7130725B2 (en) * 2004-12-17 2006-10-31 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method for correcting control surface angle measurements in single viewpoint photogrammetry

Also Published As

Publication number Publication date
ZA200801859B (en) 2009-07-29
JP2009502177A (ja) 2009-01-29
ATE523193T1 (de) 2011-09-15
JP5132557B2 (ja) 2013-01-30
CA2641599C (en) 2012-07-10
BRPI0615958B1 (pt) 2020-11-10
US8632963B2 (en) 2014-01-21
EP1924252B1 (en) 2011-09-07
PT1924252E (pt) 2011-12-16
SI1924252T1 (sl) 2011-12-30
AU2006275632B2 (en) 2011-11-03
AU2006275632A1 (en) 2007-02-08
DK1924252T3 (da) 2011-11-14
CA2641599A1 (en) 2007-02-08
ES2372538T3 (es) 2012-01-23
CN101272773A (zh) 2008-09-24
BRPI0615958A2 (pt) 2011-05-31
WO2007016379A2 (en) 2007-02-08
CY1111959T1 (el) 2015-11-04
EP1924252A4 (en) 2010-03-17
US20070042358A1 (en) 2007-02-22
PL1924252T3 (pl) 2012-02-29
EP1924252A2 (en) 2008-05-28
WO2007016379A3 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
CY1111959T1 (el) Μεθοδος για την βελτιωση της διαπερατοτητας των κυτταρων σε ξενα σωματιδια
Nuccio et al. HT-SIP: a semi-automated stable isotope probing pipeline identifies cross-kingdom interactions in the hyphosphere of arbuscular mycorrhizal fungi
Gutarowska et al. Metabolomic and high-throughput sequencing analysis—modern approach for the assessment of biodeterioration of materials from historic buildings
Del Prado et al. Culture, method, and the content of self-concepts: Testing trait, individual–self-primacy, and cultural psychology perspectives
WO2004076683A3 (en) Random array dna analysis by hybridization
DE60210621D1 (de) Universelle methode und zusammensetzung zur schnellen lysierung von zellen zur freisetzung von nukleinsäuren und ihre detektion
WO2010083250A3 (en) Single-cell nucleic acid analysis
EP4574995A3 (en) Methods and kits for detection of methylation status
EP4310183A3 (en) Methods and systems for droplet-based single cell barcoding
MX2009004043A (es) Incorporacion genetica de aminoacidos no naturales a proteinas en celulas mamiferas.
EP4524246A3 (en) Methods and compositions for the extraction and amplification of nucleic acid from a sample
WO2007092916A3 (en) Methods of extracting rna
WO2007035684A3 (en) Method for quantitative detection of short rna molecules
Marschner Soil microbial community structure and function assessed by FAME, PLFA and DGGE—advantages and limitations
WO2008066858A3 (en) Method of separating target dna from mixed dna
ATE452187T1 (de) Methode zur isolation von nukleinsäuren
Ray et al. RNAase P is dependent on RNAase E action in processing monomeric RNA precursors that accumulate in an RNAase E− mutant of Escherichia coli
JP2023521803A (ja) ウイルス核酸の検出用製品及びその検出方法
WO2010039189A3 (en) Methods for sequencing degraded or modified nucleic acids
GB0503172D0 (en) Detection method
EP4410970A3 (en) Efficient cell culture system for hepatitis c virus genotype 6a
WO2023215524A3 (en) Primary template-directed amplification and methods thereof
WO2008049583A3 (de) Verfahren zur selektiven lokalisierung von wirkstoffen an und in mitochondrien und entsprechende wirkstoffe
CA2639414A1 (en) Membrane concentration assay with nucleic acid cleavage for measuring a component of whole blood
Gärtner et al. Development of immortalized Callithrix jacchus kidney cell lines supporting infection with a panel of viruses

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/11/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/07/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2785 DE 21-05-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.